Choose Language
Select a language for news translation.
Senators question Kevin Lilly’s nomination for Fish and Wildlife Assistant Secretary due to his lack of conservation experience, raising concerns about weakene…
Written by Reuben Gregg Brewer for The Motley Fool -> Eli Lilly is a market darling because it is a leader in the GLP-1 weight-loss market. Pfizer hasn't eve…
EXCLUSIVE: Lilly Wachoswki is setting a different kind of stage for her next project, hosting a live reading of her dystopian political thriller The Hunted, cu…
Written by Reuben Gregg Brewer for The Motley Fool -> Novo Nordisk was the first to market with a GLP-1 weight-loss drug. It lost its early lead to Eli Lilly…
Written by Prosper Junior Bakiny for The Motley Fool -> Eli Lilly is posting strong results, and that should continue. The drugmaker is dominating in its cor…
Written by Prosper Junior Bakiny for The Motley Fool -> Vertex Pharmaceuticals and Eli Lilly are both going after the non-opioid pain management market. Vert…
Written by Eric Trie for The Motley Fool -> Simplify Health Care ETF carries a higher expense ratio but has significantly outperformed iShares U.S. Healthcare…
